2023
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management
Wei B, Fox L, Kaffenberger B, Korman A, Micheletti R, Mostaghimi A, Noe M, Rosenbach M, Shinkai K, Kwah J, Phillips E, Bolognia J, Damsky W, Nelson C. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management. Journal Of The American Academy Of Dermatology 2023, 90: 911-926. PMID: 37516356, DOI: 10.1016/j.jaad.2023.02.073.Peer-Reviewed Original ResearchSevere cutaneous adverse reactionsCutaneous adverse reactionsSystemic symptomsDrug reactionsAdverse reactionsDifferential diagnosisDrug-induced hypersensitivity syndrome/drug reactionDrug-induced hypersensitivity syndromeDiHS/DRESSVisceral organ involvementSteroid-sparing agentCornerstone of managementFirst-line therapyEvidence-based overviewSystemic corticosteroidsHypersensitivity syndromeImmediate discontinuationOrgan involvementRisk stratificationAutoimmune diseasesAdjunctive testNeoplastic disordersDiagnostic criteriaLongitudinal evaluationDiagnosisDrug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis
Wei B, Fox L, Kaffenberger B, Korman A, Micheletti R, Mostaghimi A, Noe M, Rosenbach M, Shinkai K, Kwah J, Phillips E, Bolognia J, Damsky W, Nelson C. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis. Journal Of The American Academy Of Dermatology 2023, 90: 885-908. PMID: 37516359, DOI: 10.1016/j.jaad.2023.02.072.Peer-Reviewed Original ResearchSevere cutaneous adverse reactionsDiHS/DRESSClinicopathological featuresSystemic symptomsDrug reactionsDrug-induced hypersensitivity syndrome/drug reactionDrug-induced hypersensitivity syndromePart I. EpidemiologyVisceral organ involvementCutaneous adverse reactionsRisk of relapseHypersensitivity syndromeOrgan involvementI. EpidemiologyOrgan dysfunctionSignificant morbidityAutoimmune diseasesAdverse reactionsDrug exposureT cellsCommon triggerImmune systemPathogenesisEosinophiliaMedical education activitiesEarly Detection and Prognostic Assessment of Cutaneous Melanoma
Kashani-Sabet M, Leachman S, Stein J, Arbiser J, Berry E, Celebi J, Curiel-Lewandrowski C, Ferris L, Grant-Kels J, Grossman D, Kulkarni R, Marchetti M, Nelson K, Polsky D, Seiverling E, Swetter S, Tsao H, Verdieck-Devlaeminck A, Wei M, Bar A, Bartlett E, Bolognia J, Bowles T, B. K, Chu E, Hartman R, Hawryluk E, Jampel R, Karapetyan L, Kheterpal M, Lawson D, Leming P, Liebman T, Ming M, Sahni D, Savory S, Shaikh S, Sober A, Sondak V, Spaccarelli N, Usatine R, Venna S, Kirkwood J. Early Detection and Prognostic Assessment of Cutaneous Melanoma. JAMA Dermatology 2023, 159: 545-553. PMID: 36920356, PMCID: PMC11225588, DOI: 10.1001/jamadermatol.2023.0127.Peer-Reviewed Original ResearchConceptsRisk-stratified approachCutaneous melanomaGEP scorePrognostic assessmentGene expression profile testingMelanoma screeningEarly detectionLow-risk histologyNegative nodal statusDelphi consensus methodReflectance confocal microscopyNodal statusSentinel lymphAdvanced melanomaHistologic featuresScreening eventsScreening practicesConsensus statementConsensus recommendationsSkin lesionsDermoscopic examinationGEP testingConsensus conferenceMelanocytic skin lesionsClinical setting31 Folliculites
Bolognia J, Schaffer J, Duncan K, Ko C. 31 Folliculites. 2023, 282-297. DOI: 10.1016/b978-2-294-77853-7.00031-7.Peer-Reviewed Original Research6 Psoriasis
Bolognia J, Schaffer J, Duncan K, Ko C. 6 Psoriasis. 2023, 57-71. DOI: 10.1016/b978-2-294-77853-7.00006-8.Peer-Reviewed Original Research43 Désordres nutritionnels
Bolognia J, Schaffer J, Duncan K, Ko C. 43 Désordres nutritionnels. 2023, 379-395. DOI: 10.1016/b978-2-294-77853-7.00043-3.Peer-Reviewed Original Research1 Principes de base en dermatologie
Bolognia J, Schaffer J, Duncan K, Ko C. 1 Principes de base en dermatologie. 2023, 1-20. DOI: 10.1016/b978-2-294-77853-7.00001-9.Peer-Reviewed Original Research17 Réactions aux médicaments
Bolognia J, Schaffer J, Duncan K, Ko C. 17 Réactions aux médicaments. 2023, 159-183. DOI: 10.1016/b978-2-294-77853-7.00017-2.Peer-Reviewed Original Research45 Manifestations cutanées des maladies systémiques
Bolognia J, Schaffer J, Duncan K, Ko C. 45 Manifestations cutanées des maladies systémiques. 2023, 403-423. DOI: 10.1016/b978-2-294-77853-7.00045-7.Peer-Reviewed Original Research21 Dermatoses neutrophiliques
Bolognia J, Schaffer J, Duncan K, Ko C. 21 Dermatoses neutrophiliques. 2023, 211-220. DOI: 10.1016/b978-2-294-77853-7.00021-4.Peer-Reviewed Original Research97 Lymphomes cutanés àcellulesB
Bolognia J, Schaffer J, Duncan K, Ko C. 97 Lymphomes cutanés àcellulesB. 2023, 993-1000. DOI: 10.1016/b978-2-294-77853-7.00097-4.Peer-Reviewed Original Research76 Histiocytoses
Bolognia J, Schaffer J, Duncan K, Ko C. 76 Histiocytoses. 2023, 789-794. DOI: 10.1016/b978-2-294-77853-7.00076-7.Peer-Reviewed Original Research44 Maladie du greffon contre l'hôte
Bolognia J, Schaffer J, Duncan K, Ko C. 44 Maladie du greffon contre l'hôte. 2023, 396-402. DOI: 10.1016/b978-2-294-77853-7.00044-5.Peer-Reviewed Original Research71 Infestations
Bolognia J, Schaffer J, Duncan K, Ko C. 71 Infestations. 2023, 733-741. DOI: 10.1016/b978-2-294-77853-7.00071-8.Peer-Reviewed Original Research12 Dermatites de contact irritatives et allergiques, dermatoses professionnelles et dermatoses dues aux plantes
Bolognia J, Schaffer J, Duncan K, Ko C. 12 Dermatites de contact irritatives et allergiques, dermatoses professionnelles et dermatoses dues aux plantes. 2023, 115-126. DOI: 10.1016/b978-2-294-77853-7.00012-3.Peer-Reviewed Original Research30 Rosacée et dermatite périorificielle
Bolognia J, Schaffer J, Duncan K, Ko C. 30 Rosacée et dermatite périorificielle. 2023, 274-281. DOI: 10.1016/b978-2-294-77853-7.00030-5.Peer-Reviewed Original Research60 Maladies anogénitales
Bolognia J, Schaffer J, Duncan K, Ko C. 60 Maladies anogénitales. 2023, 585-598. DOI: 10.1016/b978-2-294-77853-7.00060-3.Peer-Reviewed Original Research35 Sclérodermie systémique et affections sclérodermoïdes
Bolognia J, Schaffer J, Duncan K, Ko C. 35 Sclérodermie systémique et affections sclérodermoïdes. 2023, 326-337. DOI: 10.1016/b978-2-294-77853-7.00035-4.Peer-Reviewed Original Research40 Maladies de surcharge
Bolognia J, Schaffer J, Duncan K, Ko C. 40 Maladies de surcharge. 2023, 365-367. DOI: 10.1016/b978-2-294-77853-7.00040-8.Peer-Reviewed Original Research92 Néoplasmes mélanocytaires bénins
Bolognia J, Schaffer J, Duncan K, Ko C. 92 Néoplasmes mélanocytaires bénins. 2023, 930-949. DOI: 10.1016/b978-2-294-77853-7.00092-5.Peer-Reviewed Original Research